HCV DOOMED BEFORE IT STARTS

[Anonymous]

Great attitude. Keep up the good work!

 

[Anonymous]

Let's put a pin in that idea and come back to it. Right now, go to your flip charts and diagram AbbVie's future. Pick someone to report out findings.

 

[Anonymous]

If you guys do not in-license a Nuc from Idenix....You are screwed!

 

[Anonymous]

Help me understand why a nuc is more important than a PI in HIV and now HCV!!! I have always been told PIs are better!! What is the truth Lootz?

 

[Anonymous]

Help me understand why a nuc is more important than a PI in HIV and now HCV!!! I have always been told PIs are better!! What is the truth Lootz?

You DON'T want to know the Truth, the Truth will hurt you!

 

[Anonymous]

Abbvie is going to need very strong reps in order to be successful. Industry / GI and Hep vets who are known commodities and trusted by doctors. There's a lot that'll need to be done regarding access etc. Compound that by not being first to market at a company with a CIA vs a company like Gillead who will pull out all the stops.

Hcv may be a little different, but your dealing with a very skeptical audience who have not forgotten the Vertex and Merck debacle.

Sure salaries are nice, but it'll be needed when no ones making bonus.

 

[Anonymous]

Abbvie is going to need very strong reps in order to be successful. Industry / GI and Hep vets who are known commodities and trusted by doctors. There's a lot that'll need to be done regarding access etc. Compound that by not being first to market at a company with a CIA vs a company like Gillead who will pull out all the stops.

Hcv may be a little different, but your dealing with a very skeptical audience who have not forgotten the Vertex and Merck debacle.

Sure salaries are nice, but it'll be needed when no ones making bonus.

If bonuses are not being made then salaries will be stopped as well!!! Join the Gilead Team!!

 

[Anonymous]

If bonuses are not being made then salaries will be stopped as well!!! Join the Gilead Team!!

Ok where do I sign up. We are not going to be able to sell any of this crsap.

 

[Anonymous]

Only Marketing person worth a hoot is this gal named Kezium - - - was impressed. The rest are little yes robots! Ugh!!!!!

 

[Anonymous]

If Gileads drug works, and BMSs drug works, then what's lefIt's curative right? If they don't work, you'll have to be one heck of a magician to convince docs to keep it rolling to try a 3rd expensive option. Merck was #2 and dead in the water at launch.

And, studies have shown more hep c patients die on these drugs than when not treated at all. Say what?!

 

[Anonymous]

Only Marketing person worth a hoot is this gal named Kezium - - - was impressed. The rest are little yes robots! Ugh!!!!!

Agree - probably the only competent one in the bunch! Maybe she can help Lootz come to his senses! The launch is going to be a disaster for everyone!!

 

[Anonymous]

These new treatments are curative right? So what's left if your 3rd into a market? Your only saving grace will be if your managed care team can negotiate preferred tier 2 status for abbvie with a step edit for all your competitors.

You'd better pray your competitors drugs fall short. Then, you can sell provided you can use a message worthwhile under a restrictive CIA.

 

[Anonymous]

Internal here, I heard one of the Houston reps quit. Is this ship going down? Not sure I want to jump to HCV.

 

[Anonymous]

Go Go Gilead!

 

[Anonymous]

Be a light and not a judge!

 

[Anonymous]

You folks clearly haven't been paying attention. Remember Vertex, Merck? Vertex had a three year run, Merck never took off. So the great American dream and formula for treatments is very different when your talking $85000 and curative.

Abbvie is PIP crazy so get ready. I hope you got a phat base salary because bonuses aren't coming.

 

[Anonymous]

ANTIQUATED REGIMEN WITH TOXIC NORVIR! NO WAY THIS IS GOING TO SELL!! JOIN ACHILLION NOW!

 

[Anonymous]

I will advise Dave that I will turn down offer.

 

[Anonymous]

This is what Wall Street is saying! What do you say General Lootz and Sergeant Shultzes!! Tell us how we are going to compete!!! Maybe, the Marketing Buffoons are making a glossy sales brochure!! "Sovaldi has a 90 percent-plus cure rate with a single daily dose and no side effects, while AbbVie's drug offers the same cure rate, but the therapy proposes intake of multiple pills per day and some probable side effects. It seems pretty obvious that Solvadi is the Holy Grail for hepatitis C patients."

 

[Anonymous]

External - just contacted about an HCV opening....came in here to peek at what people are saying....

and...running...fast.